首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

2004550

髂动脉支架市场报告：趋势、预测及竞争分析（至2035年）

Iliac Stent Market Report: Trends, Forecast and Competitive Analysis to 2035

出版日期: 2026年03月31日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球髂动脉支架市场前景广阔，预计在医院和门诊领域都有发展机会。 2026年至2035年，全球髂动脉支架市场预计将以5.5%的复合年增长率成长，到2035年市场规模预计将达到23亿美元。推动市场成长的主要因素包括周边动脉疾病盛行率的上升、对微创治疗需求的成长以及先进支架技术的广泛应用。

根据 Lucintel 的预测，根据所使用的支架类型，自动扩张型支架在预测期内预计将呈现更高的成长率。
从应用场景来看，门诊设施预计将呈现更高的成长率。
按地区划分，预计亚太地区在预测期内将呈现最高的成长率。

髂动脉支架市场的新趋势

髂动脉支架市场正经历快速发展，其驱动力包括技术进步、周边动脉疾病盛行率上升以及微创手术日益普及。随着医疗专业人员对更有效、更持久的解决方案的需求不断增长，市场参与者也持续创新以满足这一需求。新材料的引入、支架设计的改进以及个人化治疗方案的出现正在塑造未来的市场模式。此外，监管政策的变化和医疗成本的上涨也在影响市场动态。这些趋势共同造就了一个更具竞争性、创新性和以患者为中心的市场环境，最终将带来更好的临床疗效，并扩大患者获得先进血管介入治疗的机会。

技术创新：支架设计和材料领域正取得显着进展，包括生物可吸收支架和药物释放型支架。这些创新旨在提高血管通畅率、降低血管再阻塞并增强生物相容性。此外，影像技术和输送系统的改进提高了手术精度并降低了创伤性。这一趋势正在推动新一代髂动脉支架的研发，这些支架具有更高的耐用性、柔软性和更好的患者预后，从而扩大了微创血管介入治疗的范围。
周边动脉疾病(PAD) 发病率上升：全球 PAD 病例数量不断增加，这主要归因于人口老化、糖尿病和生活方式因素，从而推动了对髂动脉支架的需求。随着越来越多的患者需要接受血管重建手术，市场正在扩大。这一趋势凸显了对能够解决复杂病变并改善患者生活品质的耐用有效支架解决方案的需求。不断成长的患者群体也促使医疗专业人员采用先进的支架留置技术，进一步推动了市场成长。
微创手术的兴起：从传统开放性手术转向微创血管内置入术技术是一个显着的趋势。髂动脉支架置放术可缩短恢復时间、降低併发症率并最大限度地减少手术相关不适。影像和输送系统的技术进步推动了这一趋势，提高了手术的安全性和可及性。随着患者偏好和临床指南推荐微创方案，髂动脉支架置入术市场预计将稳定成长，其应用范围也将扩展到所有医疗机构。
监管和报销体系的变化：监管标准和报销政策的演变正在影响市场动态。新支架器械核准流程的收紧促进了创新，但也可能为市场准入带来挑战。另一方面，优惠的报销政策奖励医疗机构采用先进的支架治疗方案。这些监管和财务因素正在影响产品开发、定价策略和市场准入，重塑竞争格局，并促使企业更加重视合规性和以价值为导向的医疗保健。
市场扩张与地理成长：亚太、拉丁美洲和中东等新兴市场的医疗基础设施不断完善，人们对血管疾病的认知度也日益提高。这种扩张为髂动脉支架製造商带来了巨大的成长机会。在地化生产、策略合作以及针对区域市场量身定制的产品方案正在推动这些地区的市场渗透。随着医疗服务可及性的提升和经济状况的趋于稳定，预计这些市场将为全球市场成长做出重大贡献，丰富竞争组织，并促进创新。

总而言之，这些趋势正透过促进创新、扩大应用范围和改善患者预后，全面改变髂动脉支架市场。技术进步、人口结构变化、治疗方法偏好、监管环境以及对地理扩张的关注，共同创造了一个充满活力的环境，为持续成长和发展奠定了基础。

髂动脉支架市场的最新趋势

髂动脉支架市场正经历快速成长，这主要得益于技术进步、血管疾病盛行率上升以及全球医疗基础设施的不断改进。支架设计和材料的创新正在改善患者的治疗效果，而公众意识的提高和筛检项目的广泛应用也推动了市场需求。此外，策略合作和监管核准也促进了市场扩张。市场的发展趋势反映了对微创手术和个人化医疗的关注，为永续成长奠定了基础。这些趋势正在重塑市场格局，为相关人员带来新的机会，并有助于提升全球患者照护水准。

支架技术创新：先进的髂动脉支架的研发，凭藉其更高的柔软性、耐用性和生物相容性，正在改变治疗选择。新材料和设计改进降低了血管再阻塞和併发症率，从而改善了长期疗效。这项创新吸引了寻求有效且微创解决方案的医疗专业人员，进而推动了市场扩张。随着研究的深入，药物释放型支架和生物可吸收支架的整合可望进一步改变市场模式，提供满足不同患者需求的个人治疗方法。
血管疾病盛行率上升：全球周边动脉疾病和动脉粥状硬化的发生率不断上升，显着推动了髂动脉支架的需求。老化和生活方式因素加剧了血管健康问题，需要更多治疗性介入。早期诊断和筛检项目的改进，使得更多适合支架置入术的患者得以识别，扩大了患者群体。这一趋势凸显了对更便利、更有效治疗方法的需求，推动了市场成长，并激励製造商进行创新和提高产量。
医疗基础设施的扩张：医疗设施的增加，尤其是在新兴国家，正在促进血管疾病治疗的普及。对配备先进诊断和手术设备的医院和诊所的投资，推动了手术数量的成长。政府措施和官民合作关係进一步促进了基础设施建设。这种扩建将增加髂动脉支架手术的可近性，降低治疗成本，加快市场渗透，最终改善患者预后，并推动产业成长。
策略合作与监管核准：医疗设备製造商与医疗服务提供者之间的合作正在加速产品开发和商业化。在美国和欧洲等关键市场获得监管核准，正推动创新支架的广泛应用。这些策略性措施有助于产品进入市场，确保合规性，并增强消费者信心。随着核准和合作的增加，市场将受益于更广泛的先进医疗设备，竞争也将加剧，并促进创新以满足多样化的临床需求。
微创手术需求日益增长：微创治疗方法的转变是髂动脉支架市场的主要驱动力。由于患者倾向于恢復时间更短、併发症更少的手术，临床医生越来越多地采用血管内介入技术。这种需求促使製造商开发出操作简单、性能卓越且与微创手术相容的支架。这一趋势提高了手术成功率和患者满意度，从而扩大了支架的应用范围并促进了市场成长，尤其是在门诊和近门诊环境中。

这些趋势共同推动了髂动脉支架市场的显着成长。技术创新、疾病盛行率上升、基础设施扩建、策略合作以及患者对微创手术的偏好，共同创造了一个充满活力的市场环境。这种发展不仅扩大了市场规模，也有助于改善治疗效果和提高医疗服务的可近性。随着这些因素的持续演变，预计市场将保持持续成长，为相关人员带来广泛的机会，并为全球患者提供更优质的医疗解决方案。

The future of the global iliac stent market looks promising with opportunities in the hospital and outpatient facility markets. The global iliac stent market is expected to reach an estimated $2.3 billion by 2035 with a CAGR of 5.5% from 2026 to 2035. The major drivers for this market are the increasing prevalence of peripheral artery diseases, the rising demand for minimally invasive treatments, and the growing adoption of advanced stent technologies.

Lucintel forecasts that, within the type category, self-expandable stent is expected to witness higher growth over the forecast period.
Within the end use category, outpatient facility is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Iliac Stent Market

The iliac stent market is experiencing rapid evolution driven by technological advancements, increasing prevalence of peripheral artery disease, and a growing emphasis on minimally invasive procedures. As healthcare providers seek more effective and durable solutions, market players are innovating to meet these demands. The integration of new materials, improved stent designs, and personalized treatment options is shaping the future landscape. Additionally, regulatory changes and rising healthcare expenditure are influencing market dynamics. These developments collectively contribute to a more competitive, innovative, and patient-centric market environment, ultimately improving clinical outcomes and expanding access to advanced vascular interventions.

Technological Innovation: The market is witnessing significant advancements in stent design and materials, such as bioresorbable and drug-eluting stents. These innovations aim to improve patency rates, reduce restenosis, and enhance biocompatibility. Enhanced imaging and delivery systems are also making procedures more precise and less invasive. This trend is driving the development of next-generation iliac stents that offer better durability, flexibility, and patient outcomes, thereby expanding the scope of minimally invasive vascular interventions.
Rising Prevalence of Peripheral Artery Disease: An increase in PAD cases globally, driven by aging populations, diabetes, and lifestyle factors, is fueling demand for iliac stents. As more patients require revascularization procedures, the market expands. This trend underscores the need for durable, effective stent solutions that can address complex lesions and improve quality of life. The growing patient pool is also encouraging healthcare providers to adopt advanced stenting techniques, further propelling market growth.
Adoption of Minimally Invasive Procedures: The shift from traditional open surgeries to minimally invasive endovascular techniques is a key trend. Iliac stenting offers reduced recovery times, lower complication rates, and less procedural discomfort. This trend is supported by technological improvements in imaging and delivery systems, making procedures safer and more accessible. As patient preference and clinical guidelines favor minimally invasive options, the market for iliac stents is expected to grow steadily, with increased adoption across healthcare settings.
Regulatory and Reimbursement Changes: Evolving regulatory standards and reimbursement policies are impacting market dynamics. Stricter approval processes for new stent devices are encouraging innovation but may also pose challenges for market entry. Conversely, favorable reimbursement policies are incentivizing healthcare providers to adopt advanced stenting solutions. These regulatory and financial factors influence product development, pricing strategies, and market accessibility, shaping the competitive landscape and encouraging companies to focus on compliance and value-based care.
Market Expansion and Geographic Growth: Emerging markets in Asia-Pacific, Latin America, and the Middle East are experiencing increased healthcare infrastructure development and rising awareness about vascular diseases. This expansion offers significant growth opportunities for iliac stent manufacturers. Local manufacturing, strategic partnerships, and tailored product offerings are facilitating market penetration in these regions. As healthcare access improves and economic conditions stabilize, these markets are expected to contribute substantially to global market growth, diversifying the competitive landscape and fostering innovation.

In summary, these trends are collectively transforming the iliac stent market by fostering innovation, expanding access, and improving patient outcomes. The focus on technological advancements, demographic shifts, procedural preferences, regulatory landscapes, and geographic expansion is creating a dynamic environment that is poised for sustained growth and evolution.

Recent Developments in the Iliac Stent Market

The iliac stent market is experiencing rapid growth driven by technological advancements, increasing vascular disease prevalence, and expanding healthcare infrastructure worldwide. Innovations in stent design and materials are improving patient outcomes, while rising awareness and screening programs are boosting demand. Additionally, strategic collaborations and regulatory approvals are facilitating market expansion. The markets evolution reflects a focus on minimally invasive procedures and personalized treatments, positioning it for sustained growth. These developments are reshaping the landscape, offering new opportunities for stakeholders and improving patient care globally.

Innovation in Stent Technology: The development of advanced iliac stents with improved flexibility, durability, and biocompatibility is transforming treatment options. New materials and design enhancements reduce restenosis and complications, leading to better long-term outcomes. This innovation attracts healthcare providers seeking effective, minimally invasive solutions, thereby expanding market reach. As research continues, the integration of drug-eluting and bioresorbable stents is expected to further revolutionize the market, offering tailored therapies for diverse patient needs.
Increasing Prevalence of Vascular Diseases: The rising incidence of peripheral artery disease and atherosclerosis globally is significantly driving iliac stent demand. Aging populations and lifestyle factors contribute to vascular health issues, prompting more interventions. Early diagnosis and improved screening programs are identifying candidates for stenting procedures, expanding the patient base. This trend underscores the need for accessible, effective treatment options, fueling market growth and encouraging manufacturers to innovate and scale production.
Expanding Healthcare Infrastructure: Growth in healthcare facilities, especially in emerging economies, is facilitating wider access to vascular interventions. Investments in hospitals and clinics equipped with advanced diagnostic and surgical tools are increasing procedural volumes. Government initiatives and public-private partnerships are further supporting infrastructure development. This expansion enhances the availability of iliac stent procedures, reduces treatment costs, and accelerates market penetration, ultimately improving patient outcomes and fostering industry growth.
Strategic Partnerships and Regulatory Approvals: Collaborations between medical device companies and healthcare providers are accelerating product development and commercialization. Regulatory approvals in key markets, such as the U.S. and Europe, are enabling wider adoption of innovative stents. These strategic moves streamline market entry, ensure compliance, and boost consumer confidence. As approvals and partnerships multiply, the market benefits from a broader portfolio of advanced devices, increasing competition, and driving innovation to meet diverse clinical needs.
Rising Demand for Minimally Invasive Procedures: The shift towards less invasive treatments is a key driver in the iliac stent market. Patients prefer procedures with shorter recovery times and fewer complications, prompting clinicians to adopt endovascular techniques. This demand encourages manufacturers to develop user-friendly, high-performance stents compatible with minimally invasive approaches. The trend enhances procedural success rates and patient satisfaction, leading to increased adoption and market expansion, especially in outpatient and outpatient-like settings.

These developments collectively are propelling the iliac stent market towards significant growth. Technological innovations, rising disease prevalence, infrastructure expansion, strategic collaborations, and patient preferences for minimally invasive procedures are creating a dynamic environment. This evolution is not only expanding market size but also improving treatment outcomes and accessibility. As these factors continue to evolve, the market is poised for sustained growth, offering promising opportunities for industry stakeholders and better healthcare solutions for patients worldwide.

Strategic Growth Opportunities in the Iliac Stent Market

The iliac stent market is experiencing significant growth driven by increasing peripheral artery disease cases, technological advancements, and expanding healthcare infrastructure. Rising awareness and demand for minimally invasive procedures further propel market expansion. Key applications across various medical settings are creating new opportunities for manufacturers and healthcare providers. Strategic investments and innovation are essential to capitalize on these trends, ensuring improved patient outcomes and market competitiveness. This dynamic environment offers substantial potential for growth, making it a critical focus for stakeholders aiming to enhance vascular intervention solutions.

Increasing Prevalence of Peripheral Artery Disease: The rising incidence of peripheral artery disease (PAD) globally is a primary driver for iliac stent adoption. As PAD progresses, patients require minimally invasive interventions like iliac stenting to restore blood flow. The aging population and lifestyle-related risk factors contribute to this trend, expanding the patient pool. Healthcare providers are increasingly opting for iliac stents over traditional surgery due to reduced recovery times and improved outcomes, fueling market growth.
Advancements in Stent Technology and Materials: Innovations in stent design, such as drug-eluting and bioresorbable stents, are enhancing treatment efficacy and patient safety. New materials improve flexibility, durability, and biocompatibility, reducing complications like restenosis. These technological advancements enable more precise placement and longer-lasting results, encouraging wider adoption. Continuous R&D efforts are expected to introduce next-generation stents, further expanding the market and offering tailored solutions for diverse patient needs.
Rising Demand for Minimally Invasive Procedures: The shift towards minimally invasive vascular interventions is a significant growth factor. Iliac stenting offers a less traumatic alternative to open surgery, with shorter hospital stays and quicker recovery. Patients and clinicians prefer these procedures for their safety and convenience. As healthcare systems prioritize outpatient treatments, the demand for iliac stents increases, prompting manufacturers to develop user-friendly, cost-effective devices that support minimally invasive techniques.
Expanding Healthcare Infrastructure and Access: Growing healthcare infrastructure, especially in emerging economies, improves access to vascular treatments. Investments in hospitals and specialized clinics facilitate the adoption of iliac stenting procedures. Government initiatives and public-private partnerships aim to enhance diagnostic and treatment facilities, broadening patient reach. This expansion supports market growth by enabling more widespread use of iliac stents, particularly in regions with previously limited access to advanced vascular care.
Strategic Partnerships and Market Consolidation: Collaborations between device manufacturers, healthcare providers, and research institutions foster innovation and market expansion. Mergers and acquisitions consolidate market share, streamline product portfolios, and accelerate development of advanced stents. Strategic partnerships also facilitate clinical trials and regulatory approvals, boosting product credibility. These activities help companies penetrate new markets and meet evolving clinical demands, ensuring sustained growth and competitiveness in the iliac stent market.

The overall impact of these opportunities is a robust expansion of the iliac stent market, driven by technological innovation, increased disease prevalence, and improved healthcare access. Stakeholders who leverage these growth avenues can enhance treatment outcomes, expand their market presence, and meet the rising demand for minimally invasive vascular solutions. This evolving landscape promises sustained growth and innovation, shaping the future of vascular intervention therapies.

Iliac Stent Market Driver and Challenges

The iliac stent market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive procedures and stent technology have increased the adoption of iliac stents worldwide. Economic factors such as rising healthcare expenditure and increasing prevalence of peripheral artery disease (PAD) further propel market expansion. Regulatory approvals and guidelines ensure safety and efficacy, fostering confidence among healthcare providers and patients. However, challenges like high costs, stringent regulatory processes, and technological limitations pose hurdles. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities.

The factors responsible for driving the iliac stent market include:

Technological Innovations: The development of advanced stent materials and designs, such as drug-eluting and bioresorbable stents, has significantly improved patient outcomes. These innovations reduce restenosis rates and enhance durability, making procedures more effective and appealing to clinicians. Continuous R&D efforts are leading to more precise, minimally invasive interventions, which expand the patient pool eligible for treatment. As technology advances, costs tend to decrease, further promoting adoption across various healthcare settings. The integration of imaging and navigation systems also enhances procedural accuracy, boosting confidence among practitioners and patients alike.
Increasing Prevalence of Peripheral Artery Disease (PAD): The rising incidence of PAD, especially among aging populations and those with diabetes or hypertension, is a major growth driver. As PAD progresses, patients often require revascularization procedures, including iliac stent placement. The growing burden of cardiovascular diseases globally, coupled with lifestyle changes and urbanization, has led to increased diagnosis and treatment rates. This trend directly correlates with higher demand for minimally invasive solutions like iliac stents, fueling market expansion. Governments and healthcare providers are prioritizing early diagnosis and intervention, further supporting market growth.
Favorable Reimbursement Policies: Improved reimbursement frameworks in many regions have made iliac stent procedures more accessible and affordable. Insurance coverage and government schemes reduce out-of-pocket expenses for patients, encouraging more individuals to seek treatment. Reimbursement policies that recognize the long-term cost savings of minimally invasive procedures over traditional surgery also incentivize healthcare providers to adopt iliac stents. This financial support accelerates market penetration, especially in emerging economies where cost barriers previously limited access. As reimbursement policies continue to evolve favorably, market growth is expected to accelerate further.
Growing Healthcare Infrastructure: The expansion of healthcare infrastructure, particularly in developing countries, facilitates increased access to advanced vascular interventions. Investments in hospitals, clinics, and specialized vascular centers enable more patients to receive timely diagnosis and treatment. The availability of trained healthcare professionals and modern equipment supports the adoption of iliac stents. Additionally, collaborations between public and private sectors are improving healthcare delivery, making minimally invasive procedures more widespread. This infrastructure development not only boosts current market demand but also lays the foundation for sustained growth as awareness and accessibility increase.
Rising Awareness and Screening Programs: Increased awareness about PAD and peripheral vascular diseases, along with widespread screening initiatives, has led to earlier diagnosis and intervention. Educational campaigns targeting high-risk populations promote understanding of treatment options, including iliac stents. Early detection allows for less invasive procedures, reducing complications and improving quality of life. The proliferation of screening programs in both developed and developing countries ensures a steady pipeline of patients eligible for stent placement. This heightened awareness directly correlates with increased procedure volumes, supporting overall market growth.

The challenges facing this iliac stent market include:

High Cost of Devices and Procedures: The advanced technology involved in manufacturing iliac stents, especially drug-eluting and bioresorbable types, results in high device costs. Additionally, procedural expenses, including hospital stays and specialist fees, can be prohibitive for some patients and healthcare systems. This financial barrier limits access, particularly in low- and middle-income countries, restricting market growth. Reimbursement limitations and budget constraints further exacerbate the issue, making it difficult for providers to adopt the latest technologies widely. Overcoming cost-related challenges is crucial for expanding market reach and ensuring equitable access to treatment.
Stringent Regulatory Environment: The approval process for new iliac stent devices involves rigorous testing and compliance with safety and efficacy standards set by regulatory authorities. Lengthy approval timelines and complex documentation requirements can delay product launches and market entry. Variability in regulations across regions adds complexity for manufacturers aiming for global distribution. These regulatory hurdles increase costs and time-to-market, potentially discouraging innovation and limiting product availability. Navigating this landscape requires significant resources and strategic planning, which can be challenging for smaller companies and startups.
Technological Limitations and Complications: Despite advancements, certain limitations persist, such as stent thrombosis, restenosis, and device migration. These complications can lead to repeat procedures and adverse patient outcomes, impacting market confidence. Additionally, some patients may not be suitable candidates for stent placement due to anatomical or comorbid conditions. Technological limitations also include issues related to long-term durability and biocompatibility. Addressing these challenges requires ongoing research and development, which can be resource-intensive. Overcoming these limitations is essential for improving patient outcomes and expanding the market.

In summary, the iliac stent market is driven by technological innovations, increasing disease prevalence, supportive reimbursement policies, expanding healthcare infrastructure, and heightened awareness. However, high costs, regulatory complexities, and technological limitations pose significant challenges. These factors collectively influence market dynamics, with growth prospects hinging on the ability to address barriers and leverage opportunities. As technological and regulatory landscapes evolve, stakeholders must focus on cost reduction, innovation, and improved patient outcomes to sustain growth and competitiveness in this expanding market.

List of Iliac Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies iliac stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the iliac stent companies profiled in this report include-

BD
Abbott
Boston Scientific Corporation
W. L. Gore & Associates, Inc.
Medtronic
Cook
Terumo Corporation
iVascular
Getinge AB
Biotronik SE & Co KG

Iliac Stent Market by Segment

The study includes a forecast for the global iliac stent market by type, artery lesions, end use, and region.

Iliac Stent Market by Type [Value from 2019 to 2035]:

Self-expandable Stents
Balloon-expandable Stents
Others

Iliac Stent Market by Artery Lesions [Value from 2019 to 2035]:

Common Iliac Artery Lesions
Severe Calcified Lesions
Complete Obstructive Lesions

Iliac Stent Market by End Use [Value from 2019 to 2035]:

Hospitals
Outpatient Facilities
Others

Iliac Stent Market by Region [Value from 2019 to 2035]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Iliac Stent Market

The iliac stent market has experienced significant growth driven by technological advancements, increasing prevalence of peripheral artery disease, and expanding healthcare infrastructure worldwide. Countries are adopting innovative stent designs and materials to improve patient outcomes, reduce complications, and enhance procedural success rates. Regulatory approvals and rising awareness about minimally invasive treatments are further propelling market expansion. Each country's unique healthcare policies, technological adoption, and patient demographics influence the pace and nature of developments in this sector. Understanding these regional trends is crucial for stakeholders aiming to capitalize on emerging opportunities and address unmet clinical needs effectively.

United States: The US market has seen rapid adoption of drug-eluting iliac stents, driven by high healthcare expenditure and advanced medical infrastructure. Innovations such as bioresorbable stents and improved imaging techniques are gaining popularity. Regulatory agencies like the FDA are approving new devices that offer better flexibility and durability, enhancing patient outcomes. The increasing prevalence of peripheral artery disease among aging populations and rising awareness about minimally invasive procedures are key factors fueling growth. Additionally, collaborations between medical device companies and healthcare providers are fostering innovation and expanding access to advanced iliac stent options.
China: China's iliac stent market is expanding due to rising cases of peripheral artery disease linked to increasing urbanization, sedentary lifestyles, and a growing aging population. The government's focus on healthcare reforms and expanding insurance coverage has improved access to vascular interventions. Local manufacturers are investing in R&D to develop cost-effective, high-quality stents tailored to regional needs. Technological adoption is accelerating, with a focus on minimally invasive procedures and improved device performance. The market is also benefiting from international collaborations and regulatory support, which facilitate the entry of advanced stent technologies into the Chinese healthcare system.
Germany: Germany's market is characterized by high adoption of innovative stent technologies, supported by a well-established healthcare system and stringent regulatory standards. The focus is on developing durable, biocompatible, and customizable iliac stents to improve long-term patency rates. Germany's emphasis on research and development, along with collaborations between academic institutions and industry, drives technological advancements. The aging population and increasing prevalence of peripheral artery disease contribute to steady market growth. Moreover, Germany's strong emphasis on minimally invasive vascular procedures and patient safety standards ensures continuous demand for advanced iliac stent solutions.
India: The Indian iliac stent market is witnessing rapid growth due to increasing cases of peripheral artery disease, driven by lifestyle changes and a rising diabetic population. The government's initiatives to improve healthcare infrastructure and affordability are facilitating wider access to vascular interventions. Local manufacturers are focusing on producing cost-effective stents that meet international quality standards, making advanced treatments more accessible. The adoption of minimally invasive techniques is increasing, supported by a growing number of trained specialists. Additionally, rising awareness and expanding healthcare coverage are expected to further propel market growth, with international companies entering the market through partnerships and regulatory approvals.
Japan: Japan's iliac stent market is characterized by high technological sophistication and a focus on innovation. The country's aging population significantly contributes to the rising demand for vascular interventions. Japan's regulatory environment encourages the development and approval of advanced stent technologies, including drug-eluting and bioresorbable options. The market benefits from strong healthcare infrastructure, extensive clinical research, and a high prevalence of peripheral artery disease. Japanese manufacturers are investing in R&D to develop next-generation stents with improved biocompatibility and long-term durability. The integration of digital health tools and minimally invasive procedures continues to shape the evolving landscape of the iliac stent market in Japan.

Features of the Global Iliac Stent Market

Market Size Estimates: Iliac stent market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
Segmentation Analysis: Iliac stent market size by type, artery lesions, end use, and region in terms of value ($B).
Regional Analysis: Iliac stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, artery lesions, end uses, and regions for the iliac stent market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the iliac stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the iliac stent market by type (self-expandable stents, balloon-expandable stents, and others), artery lesions (common iliac artery lesions, severe calcified lesions, and complete obstructive lesions), end use (hospitals, outpatient facilities, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Iliac Stent Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Self-expandable Stents : Trends and Forecast (2019-2035)
4.4 Balloon-expandable Stents : Trends and Forecast (2019-2035)
4.5 Others : Trends and Forecast (2019-2035)

5. Global Iliac Stent Market by Artery Lesions

5.1 Overview
5.2 Attractiveness Analysis by Artery Lesions
5.3 Common Iliac Artery Lesions : Trends and Forecast (2019-2035)
5.4 Severe Calcified Lesions : Trends and Forecast (2019-2035)
5.5 Complete Obstructive Lesions : Trends and Forecast (2019-2035)

6. Global Iliac Stent Market by End Use

6.1 Overview
6.2 Attractiveness Analysis by End Use
6.3 Hospitals : Trends and Forecast (2019-2035)
6.4 Outpatient Facilities : Trends and Forecast (2019-2035)
6.5 Others : Trends and Forecast (2019-2035)

7. Regional Analysis

7.1 Overview
7.2 Global Iliac Stent Market by Region

8. North American Iliac Stent Market

8.1 Overview
8.2 North American Iliac Stent Market by Type
8.3 North American Iliac Stent Market by End Use
8.4 The United States Iliac Stent Market
8.5 Canadian Iliac Stent Market
8.6 Mexican Iliac Stent Market

9. European Iliac Stent Market

9.1 Overview
9.2 European Iliac Stent Market by Type
9.3 European Iliac Stent Market by End Use
9.4 German Iliac Stent Market
9.5 French Iliac Stent Market
9.6 Italian Iliac Stent Market
9.7 Spanish Iliac Stent Market
9.8 The United Kingdom Iliac Stent Market

10. APAC Iliac Stent Market

10.1 Overview
10.2 APAC Iliac Stent Market by Type
10.3 APAC Iliac Stent Market by End Use
10.4 Chinese Iliac Stent Market
10.5 Indian Iliac Stent Market
10.6 Japanese Iliac Stent Market
10.7 South Korean Iliac Stent Market
10.8 Indonesian Iliac Stent Market

11. ROW Iliac Stent Market

11.1 Overview
11.2 ROW Iliac Stent Market by Type
11.3 ROW Iliac Stent Market by End Use
11.4 Middle Eastern Iliac Stent Market
11.5 South American Iliac Stent Market
11.6 African Iliac Stent Market

12. Competitor Analysis

12.1 Product Portfolio Analysis
12.2 Operational Integration
12.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

13.1 Value Chain Analysis
13.2 Growth Opportunity Analysis
- 13.2.1 Growth Opportunity by Type
- 13.2.2 Growth Opportunity by Artery Lesions
- 13.2.3 Growth Opportunity by End Use
13.3 Emerging Trends in the Global Iliac Stent Market
13.4 Strategic Analysis
- 13.4.1 New Product Development
- 13.4.2 Certification and Licensing
- 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

14.1 Competitive Analysis Overview
14.2 BD
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.3 Abbott
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.4 Boston Scientific Corporation
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.5 W. L. Gore & Associates, Inc.
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.6 Medtronic
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.7 Cook
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.8 Terumo Corporation
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.9 iVascular
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.10 Getinge AB
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14.11 Biotronik SE & Co KG
- Company Overview
- Iliac Stent Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

15. Appendix

15.1 List of Figures
15.2 List of Tables
15.3 Research Methodology
15.4 Disclaimer
15.5 Copyright
15.6 Abbreviations and Technical Units
15.7 About Us
15.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Iliac Stent Market
Figure 2.1: Usage of Iliac Stent Market
Figure 2.2: Classification of the Global Iliac Stent Market
Figure 2.3: Supply Chain of the Global Iliac Stent Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Iliac Stent Market
Figure 4.1: Global Iliac Stent Market by Type in 2019, 2025, and 2035
Figure 4.2: Trends of the Global Iliac Stent Market ($B) by Type
Figure 4.3: Forecast for the Global Iliac Stent Market ($B) by Type
Figure 4.4: Trends and Forecast for Self-expandable Stents in the Global Iliac Stent Market (2019-2035)
Figure 4.5: Trends and Forecast for Balloon-expandable Stents in the Global Iliac Stent Market (2019-2035)
Figure 4.6: Trends and Forecast for Others in the Global Iliac Stent Market (2019-2035)
Figure 5.1: Global Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
Figure 5.2: Trends of the Global Iliac Stent Market ($B) by Artery Lesions
Figure 5.3: Forecast for the Global Iliac Stent Market ($B) by Artery Lesions
Figure 5.4: Trends and Forecast for Common Iliac Artery Lesions in the Global Iliac Stent Market (2019-2035)
Figure 5.5: Trends and Forecast for Severe Calcified Lesions in the Global Iliac Stent Market (2019-2035)
Figure 5.6: Trends and Forecast for Complete Obstructive Lesions in the Global Iliac Stent Market (2019-2035)
Figure 6.1: Global Iliac Stent Market by End Use in 2019, 2025, and 2035
Figure 6.2: Trends of the Global Iliac Stent Market ($B) by End Use
Figure 6.3: Forecast for the Global Iliac Stent Market ($B) by End Use
Figure 6.4: Trends and Forecast for Hospitals in the Global Iliac Stent Market (2019-2035)
Figure 6.5: Trends and Forecast for Outpatient Facilities in the Global Iliac Stent Market (2019-2035)
Figure 6.6: Trends and Forecast for Others in the Global Iliac Stent Market (2019-2035)
Figure 7.1: Trends of the Global Iliac Stent Market ($B) by Region (2019-2025)
Figure 7.2: Forecast for the Global Iliac Stent Market ($B) by Region (2026-2035)
Figure 8.1: Trends and Forecast for the North American Iliac Stent Market (2019-2035)
Figure 8.2: North American Iliac Stent Market by Type in 2019, 2025, and 2035
Figure 8.3: Trends of the North American Iliac Stent Market ($B) by Type (2019-2025)
Figure 8.4: Forecast for the North American Iliac Stent Market ($B) by Type (2026-2035)
Figure 8.5: North American Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
Figure 8.6: Trends of the North American Iliac Stent Market ($B) by Artery Lesions (2019-2025)
Figure 8.7: Forecast for the North American Iliac Stent Market ($B) by Artery Lesions (2026-2035)
Figure 8.8: North American Iliac Stent Market by End Use in 2019, 2025, and 2035
Figure 8.9: Trends of the North American Iliac Stent Market ($B) by End Use (2019-2025)
Figure 8.10: Forecast for the North American Iliac Stent Market ($B) by End Use (2026-2035)
Figure 8.11: Trends and Forecast for the United States Iliac Stent Market ($B) (2019-2035)
Figure 8.12: Trends and Forecast for the Mexican Iliac Stent Market ($B) (2019-2035)
Figure 8.13: Trends and Forecast for the Canadian Iliac Stent Market ($B) (2019-2035)
Figure 9.1: Trends and Forecast for the European Iliac Stent Market (2019-2035)
Figure 9.2: European Iliac Stent Market by Type in 2019, 2025, and 2035
Figure 9.3: Trends of the European Iliac Stent Market ($B) by Type (2019-2025)
Figure 9.4: Forecast for the European Iliac Stent Market ($B) by Type (2026-2035)
Figure 9.5: European Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
Figure 9.6: Trends of the European Iliac Stent Market ($B) by Artery Lesions (2019-2025)
Figure 9.7: Forecast for the European Iliac Stent Market ($B) by Artery Lesions (2026-2035)
Figure 9.8: European Iliac Stent Market by End Use in 2019, 2025, and 2035
Figure 9.9: Trends of the European Iliac Stent Market ($B) by End Use (2019-2025)
Figure 9.10: Forecast for the European Iliac Stent Market ($B) by End Use (2026-2035)
Figure 9.11: Trends and Forecast for the German Iliac Stent Market ($B) (2019-2035)
Figure 9.12: Trends and Forecast for the French Iliac Stent Market ($B) (2019-2035)
Figure 9.13: Trends and Forecast for the Spanish Iliac Stent Market ($B) (2019-2035)
Figure 9.14: Trends and Forecast for the Italian Iliac Stent Market ($B) (2019-2035)
Figure 9.15: Trends and Forecast for the United Kingdom Iliac Stent Market ($B) (2019-2035)
Figure 10.1: Trends and Forecast for the APAC Iliac Stent Market (2019-2035)
Figure 10.2: APAC Iliac Stent Market by Type in 2019, 2025, and 2035
Figure 10.3: Trends of the APAC Iliac Stent Market ($B) by Type (2019-2025)
Figure 10.4: Forecast for the APAC Iliac Stent Market ($B) by Type (2026-2035)
Figure 10.5: APAC Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
Figure 10.6: Trends of the APAC Iliac Stent Market ($B) by Artery Lesions (2019-2025)
Figure 10.7: Forecast for the APAC Iliac Stent Market ($B) by Artery Lesions (2026-2035)
Figure 10.8: APAC Iliac Stent Market by End Use in 2019, 2025, and 2035
Figure 10.9: Trends of the APAC Iliac Stent Market ($B) by End Use (2019-2025)
Figure 10.10: Forecast for the APAC Iliac Stent Market ($B) by End Use (2026-2035)
Figure 10.11: Trends and Forecast for the Japanese Iliac Stent Market ($B) (2019-2035)
Figure 10.12: Trends and Forecast for the Indian Iliac Stent Market ($B) (2019-2035)
Figure 10.13: Trends and Forecast for the Chinese Iliac Stent Market ($B) (2019-2035)
Figure 10.14: Trends and Forecast for the South Korean Iliac Stent Market ($B) (2019-2035)
Figure 10.15: Trends and Forecast for the Indonesian Iliac Stent Market ($B) (2019-2035)
Figure 11.1: Trends and Forecast for the ROW Iliac Stent Market (2019-2035)
Figure 11.2: ROW Iliac Stent Market by Type in 2019, 2025, and 2035
Figure 11.3: Trends of the ROW Iliac Stent Market ($B) by Type (2019-2025)
Figure 11.4: Forecast for the ROW Iliac Stent Market ($B) by Type (2026-2035)
Figure 11.5: ROW Iliac Stent Market by Artery Lesions in 2019, 2025, and 2035
Figure 11.6: Trends of the ROW Iliac Stent Market ($B) by Artery Lesions (2019-2025)
Figure 11.7: Forecast for the ROW Iliac Stent Market ($B) by Artery Lesions (2026-2035)
Figure 11.8: ROW Iliac Stent Market by End Use in 2019, 2025, and 2035
Figure 11.9: Trends of the ROW Iliac Stent Market ($B) by End Use (2019-2025)
Figure 11.10: Forecast for the ROW Iliac Stent Market ($B) by End Use (2026-2035)
Figure 11.11: Trends and Forecast for the Middle Eastern Iliac Stent Market ($B) (2019-2035)
Figure 11.12: Trends and Forecast for the South American Iliac Stent Market ($B) (2019-2035)
Figure 11.13: Trends and Forecast for the African Iliac Stent Market ($B) (2019-2035)
Figure 12.1: Porter's Five Forces Analysis of the Global Iliac Stent Market
Figure 12.2: Market Share (%) of Top Players in the Global Iliac Stent Market (2025)
Figure 13.1: Growth Opportunities for the Global Iliac Stent Market by Type
Figure 13.2: Growth Opportunities for the Global Iliac Stent Market by Artery Lesions
Figure 13.3: Growth Opportunities for the Global Iliac Stent Market by End Use
Figure 13.4: Growth Opportunities for the Global Iliac Stent Market by Region
Figure 13.5: Emerging Trends in the Global Iliac Stent Market

List of Tables

Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Iliac Stent Market by Type, Artery Lesions, and End Use
Table 1.2: Attractiveness Analysis for the Iliac Stent Market by Region
Table 1.3: Global Iliac Stent Market Parameters and Attributes
Table 3.1: Trends of the Global Iliac Stent Market (2019-2025)
Table 3.2: Forecast for the Global Iliac Stent Market (2026-2035)
Table 4.1: Attractiveness Analysis for the Global Iliac Stent Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Iliac Stent Market (2019-2025)
Table 4.3: Market Size and CAGR of Various Type in the Global Iliac Stent Market (2026-2035)
Table 4.4: Trends of Self-expandable Stents in the Global Iliac Stent Market (2019-2025)
Table 4.5: Forecast for Self-expandable Stents in the Global Iliac Stent Market (2026-2035)
Table 4.6: Trends of Balloon-expandable Stents in the Global Iliac Stent Market (2019-2025)
Table 4.7: Forecast for Balloon-expandable Stents in the Global Iliac Stent Market (2026-2035)
Table 4.8: Trends of Others in the Global Iliac Stent Market (2019-2025)
Table 4.9: Forecast for Others in the Global Iliac Stent Market (2026-2035)
Table 5.1: Attractiveness Analysis for the Global Iliac Stent Market by Artery Lesions
Table 5.2: Market Size and CAGR of Various Artery Lesions in the Global Iliac Stent Market (2019-2025)
Table 5.3: Market Size and CAGR of Various Artery Lesions in the Global Iliac Stent Market (2026-2035)
Table 5.4: Trends of Common Iliac Artery Lesions in the Global Iliac Stent Market (2019-2025)
Table 5.5: Forecast for Common Iliac Artery Lesions in the Global Iliac Stent Market (2026-2035)
Table 5.6: Trends of Severe Calcified Lesions in the Global Iliac Stent Market (2019-2025)
Table 5.7: Forecast for Severe Calcified Lesions in the Global Iliac Stent Market (2026-2035)
Table 5.8: Trends of Complete Obstructive Lesions in the Global Iliac Stent Market (2019-2025)
Table 5.9: Forecast for Complete Obstructive Lesions in the Global Iliac Stent Market (2026-2035)
Table 6.1: Attractiveness Analysis for the Global Iliac Stent Market by End Use
Table 6.2: Market Size and CAGR of Various End Use in the Global Iliac Stent Market (2019-2025)
Table 6.3: Market Size and CAGR of Various End Use in the Global Iliac Stent Market (2026-2035)
Table 6.4: Trends of Hospitals in the Global Iliac Stent Market (2019-2025)
Table 6.5: Forecast for Hospitals in the Global Iliac Stent Market (2026-2035)
Table 6.6: Trends of Outpatient Facilities in the Global Iliac Stent Market (2019-2025)
Table 6.7: Forecast for Outpatient Facilities in the Global Iliac Stent Market (2026-2035)
Table 6.8: Trends of Others in the Global Iliac Stent Market (2019-2025)
Table 6.9: Forecast for Others in the Global Iliac Stent Market (2026-2035)
Table 7.1: Market Size and CAGR of Various Regions in the Global Iliac Stent Market (2019-2025)
Table 7.2: Market Size and CAGR of Various Regions in the Global Iliac Stent Market (2026-2035)
Table 8.1: Trends of the North American Iliac Stent Market (2019-2025)
Table 8.2: Forecast for the North American Iliac Stent Market (2026-2035)
Table 8.3: Market Size and CAGR of Various Type in the North American Iliac Stent Market (2019-2025)
Table 8.4: Market Size and CAGR of Various Type in the North American Iliac Stent Market (2026-2035)
Table 8.5: Market Size and CAGR of Various Artery Lesions in the North American Iliac Stent Market (2019-2025)
Table 8.6: Market Size and CAGR of Various Artery Lesions in the North American Iliac Stent Market (2026-2035)
Table 8.7: Market Size and CAGR of Various End Use in the North American Iliac Stent Market (2019-2025)
Table 8.8: Market Size and CAGR of Various End Use in the North American Iliac Stent Market (2026-2035)
Table 8.9: Trends and Forecast for the United States Iliac Stent Market (2019-2035)
Table 8.10: Trends and Forecast for the Mexican Iliac Stent Market (2019-2035)
Table 8.11: Trends and Forecast for the Canadian Iliac Stent Market (2019-2035)
Table 9.1: Trends of the European Iliac Stent Market (2019-2025)
Table 9.2: Forecast for the European Iliac Stent Market (2026-2035)
Table 9.3: Market Size and CAGR of Various Type in the European Iliac Stent Market (2019-2025)
Table 9.4: Market Size and CAGR of Various Type in the European Iliac Stent Market (2026-2035)
Table 9.5: Market Size and CAGR of Various Artery Lesions in the European Iliac Stent Market (2019-2025)
Table 9.6: Market Size and CAGR of Various Artery Lesions in the European Iliac Stent Market (2026-2035)
Table 9.7: Market Size and CAGR of Various End Use in the European Iliac Stent Market (2019-2025)
Table 9.8: Market Size and CAGR of Various End Use in the European Iliac Stent Market (2026-2035)
Table 9.9: Trends and Forecast for the German Iliac Stent Market (2019-2035)
Table 9.10: Trends and Forecast for the French Iliac Stent Market (2019-2035)
Table 9.11: Trends and Forecast for the Spanish Iliac Stent Market (2019-2035)
Table 9.12: Trends and Forecast for the Italian Iliac Stent Market (2019-2035)
Table 9.13: Trends and Forecast for the United Kingdom Iliac Stent Market (2019-2035)
Table 10.1: Trends of the APAC Iliac Stent Market (2019-2025)
Table 10.2: Forecast for the APAC Iliac Stent Market (2026-2035)
Table 10.3: Market Size and CAGR of Various Type in the APAC Iliac Stent Market (2019-2025)
Table 10.4: Market Size and CAGR of Various Type in the APAC Iliac Stent Market (2026-2035)
Table 10.5: Market Size and CAGR of Various Artery Lesions in the APAC Iliac Stent Market (2019-2025)
Table 10.6: Market Size and CAGR of Various Artery Lesions in the APAC Iliac Stent Market (2026-2035)
Table 10.7: Market Size and CAGR of Various End Use in the APAC Iliac Stent Market (2019-2025)
Table 10.8: Market Size and CAGR of Various End Use in the APAC Iliac Stent Market (2026-2035)
Table 10.9: Trends and Forecast for the Japanese Iliac Stent Market (2019-2035)
Table 10.10: Trends and Forecast for the Indian Iliac Stent Market (2019-2035)
Table 10.11: Trends and Forecast for the Chinese Iliac Stent Market (2019-2035)
Table 10.12: Trends and Forecast for the South Korean Iliac Stent Market (2019-2035)
Table 10.13: Trends and Forecast for the Indonesian Iliac Stent Market (2019-2035)
Table 11.1: Trends of the ROW Iliac Stent Market (2019-2025)
Table 11.2: Forecast for the ROW Iliac Stent Market (2026-2035)
Table 11.3: Market Size and CAGR of Various Type in the ROW Iliac Stent Market (2019-2025)
Table 11.4: Market Size and CAGR of Various Type in the ROW Iliac Stent Market (2026-2035)
Table 11.5: Market Size and CAGR of Various Artery Lesions in the ROW Iliac Stent Market (2019-2025)
Table 11.6: Market Size and CAGR of Various Artery Lesions in the ROW Iliac Stent Market (2026-2035)
Table 11.7: Market Size and CAGR of Various End Use in the ROW Iliac Stent Market (2019-2025)
Table 11.8: Market Size and CAGR of Various End Use in the ROW Iliac Stent Market (2026-2035)
Table 11.9: Trends and Forecast for the Middle Eastern Iliac Stent Market (2019-2035)
Table 11.10: Trends and Forecast for the South American Iliac Stent Market (2019-2035)
Table 11.11: Trends and Forecast for the African Iliac Stent Market (2019-2035)
Table 12.1: Product Mapping of Iliac Stent Suppliers Based on Segments
Table 12.2: Operational Integration of Iliac Stent Manufacturers
Table 12.3: Rankings of Suppliers Based on Iliac Stent Revenue
Table 13.1: New Product Launches by Major Iliac Stent Producers (2019-2025)
Table 13.2: Certification Acquired by Major Competitor in the Global Iliac Stent Market

02-2729-4219

+886-2-2729-4219

License/价格

髂动脉支架市场报告：趋势、预测及竞争分析（至2035年）

Iliac Stent Market Report: Trends, Forecast and Competitive Analysis to 2035

目录

第一章执行摘要

第二章 市场概览

第三章 市场趋势与预测分析

第四章：全球髂动脉支架市场：依类型划分

第五章：全球髂动脉支架市场：依动脉病变类型划分

第六章：全球髂动脉支架市场：依最终用途划分

第七章 区域分析

第八章：北美髂动脉支架市场

第九章：欧洲髂动脉支架市场

第十章：亚太地区髂动脉支架市场

第十一章：世界其他地区的髂动脉支架市场

第十二章 竞争分析

第十三章 机会与策略分析

第十四章：价值链中主要企业的公司概况

第十五章附录